Another study using samples from patients with ovarian epithelial cancer undergoing neoadjuvant chemotherapy reported that 30% (15/50) were PD-L1-positive before treatment (cutoff value of PD-L1 is 5%), while 53% (27/51) were PD-L1-positive after treatment (56). Here, CD274 is linked to ovarian carcinoma.